ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

Chiesi Global Rare Diseases at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Chiesi Global Rare Diseases at ASHG 2026 in Montréal: Booth 1424.

OrganizationASHG 2026 Attendance
Chiesi Global Rare Diseases
Boston, Massachusetts
Private company
A business unit established to deliver innovative therapies and solutions for people living with rare diseases.
Completed its acquisition of KalVista Pharmaceuticals, adding a rare-disease drug developer and expanding its combined R&D pipeline.
›
Completed its acquisition of KalVista Pharmaceuticals, adding a rare-disease drug developer and expanding its combined R&D pipeline.
2026-06 · source
Won EU approval to use its lomitapide capsules in children as young as 5, expanding the drug's patient population.
2026-06 · source
Entered an exclusive license agreement with Aliada Therapeutics, a wholly owned AbbVie subsidiary, adding a new pipeline program.
2025-11 · source
Source: company newsroom
Currently hiring: 29 open roles
›
Source: careers page
Booth
Exhibiting at Booth 1424
Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Chiesi Global Rare Diseases

Tell us what you sell and we’ll find the people at Chiesi Global Rare Diseases most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction